We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand the potential side effects of Onureg (azacitidine) for AML treatment, including mild and serious reactions, and learn effective management strategies for Indian patients.
Navigating the journey with Acute Myeloid Leukemia (AML) can be challenging, and treatment decisions play a pivotal role. For adults with AML in specific situations, Onureg (azacitidine) might be recommended by your doctor. This prescription medication, taken as a tablet, is designed to help manage the condition, often over the long term. However, like all medications, Onureg can come with its own set of side effects. Understanding these potential effects, both mild and serious, is key to managing your treatment effectively and ensuring your well-being. This guide aims to provide clear, practical information for Indian patients and their families, helping you communicate better with your healthcare team and cope with any challenges that arise.
Onureg, with its active ingredient azacitidine, is a vital part of certain AML treatment plans. It works by interfering with the processes that cancer cells need to grow and multiply. It’s typically administered in cycles: you’ll take the tablet for 14 days, followed by a 14-day break. This 28-day period constitutes one cycle. Your doctor will determine the exact duration and number of cycles based on your individual response and medical condition. It's important to remember that Onureg is a powerful medication, and its use should always be under the close supervision of a qualified oncologist.
While Onureg can be effective, it can also lead to side effects. Many of these are manageable and may decrease over time. Communicating openly with your doctor about any changes you experience is paramount. Some of the more commonly reported side effects include:
These are just a few of the common effects. Your doctor can provide a more comprehensive list and discuss how to manage them. Remember, side effects can be temporary, and many can be alleviated with supportive care and medical advice.
Beyond the common side effects, Onureg can cause other milder reactions. These might start out mild but can sometimes progress. It's essential to report any new or worsening symptoms to your doctor. Examples of mild side effects include:
Most of these mild side effects are temporary. Your doctor or pharmacist can offer tips for managing them. Simple strategies like staying hydrated for diarrhea, eating soft foods for mouth sores, or using over-the-counter remedies (with your doctor's approval) for mild discomfort can make a difference. However, never stop taking Onureg without consulting your doctor.
While less common, Onureg can cause serious side effects that require prompt medical intervention. Recognizing these signs and acting quickly can be life-saving. If you experience any of the following, call your doctor immediately. If the situation feels life-threatening or like a medical emergency, do not hesitate to call 108 (India's emergency number) or your local emergency services.
The list above is not exhaustive. Always refer to the official prescribing information or discuss any concerns with your healthcare provider. Prompt reporting of symptoms is your best defense.
Managing Onureg involves more than just taking the medication. It requires a holistic approach, including lifestyle adjustments and careful planning, especially concerning reproductive health.
Onureg can harm a developing fetus. Therefore, it is absolutely critical for both women and men taking Onureg to use effective contraception. The manufacturer recommends that females use birth control for at least 6 months after their last dose, and males for at least 3 months after their last dose. If you are sexually active, discuss reliable birth control methods with your doctor. If you become pregnant or suspect you might be pregnant while taking Onureg or during the recommended contraception period, inform your doctor immediately.
The decision to breastfeed while taking Onureg requires careful consideration and medical guidance. Azacitidine can pass into breast milk. The manufacturer suggests waiting 1 week after your final dose before breastfeeding. However, always follow your doctor's specific recommendations, as they will assess the risks and benefits based on your situation.
In India, while the FDA is a US agency, patients are encouraged to report any adverse drug reactions to the Central Drugs Standard Control Organization (CDSCO) or through their healthcare provider. This helps in monitoring the safety of medications and ensuring public health. Your doctor can guide you on the correct procedure for reporting side effects.
Your doctor is your most important ally in managing your AML treatment with Onureg. You should consult your doctor in the following situations:
Open and honest communication with your healthcare team ensures that your treatment is as safe and effective as possible. Don't hesitate to ask questions or express your concerns.
Living with AML and undergoing treatment can be a complex journey. Onureg offers a valuable treatment option for many, but understanding its potential side effects is essential for effective management. By staying informed, communicating openly with your doctor, and seeking prompt medical attention when needed, you can navigate your treatment with greater confidence. Remember, you are not alone in this, and your healthcare team is dedicated to supporting you every step of the way.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026